由IPSC-NSCs衍生出的异位体Let-7b-5p通过调节微质/巨质热死来改善脊髓损伤后的运动功能
Jie Liu1,2, Guang Kong3, Chenlin Lu4
1Department of Orthopaedics, Taizhou School of Clinical Medicine, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Nanjing Medical University, 366 Taihu Road, Taizhou, Jiangsu, China.
Journal of nanobiotechnology
|July 9, 2024
概括
诱导的多能干细胞-神经干细胞衍生的外体细胞 (iPSC-NSCs-Exos) 通过抑制微质/巨细胞灭,减少脊髓损伤 (SCI) 后的炎症. 这促进了神经修复,并改善了小鼠的运动功能.
科学领域:
- 神经科学是一个神经科学.
- 再生医学是一种再生医学.
- 细胞生物学 细胞生物学
背景情况:
- 脊髓损伤 (SCI) 引发由微质/巨细胞介导的神经炎症,阻碍恢复.
- 外体细胞通过miRNA转移促进细胞间通信,但它们在SCI修复中的作用尚未完全理解.
- 调查iPSC-NSCs-Exos对微质/巨细胞灭的影响对于SCI治疗至关重要.
研究的目的:
- 在小鼠SCI模型中探索iPSC-NSCs-Exos的治疗潜力.
- 为了阐明iPSC-NSCs-Exos调节微质/巨质热的机制.
- 为了在iPSC-NSCs-Exos中识别参与SCI修复的特定miRNA.
主要方法:
- 使用TEM,NTA和西方布洛特对iPSC-NSCs-Exos的表征.
- 在小鼠SCI模型上的体内和体外实验.
- 微RNA微阵列分析和救援实验,以确定miRNA功能和目标基因.
主要成果:
- 在SCI小鼠中,iPSC-NSCs-Exos抑制了微质/巨质热,保存了髓,并促进了轴突生长.
- 确定了let-7b-5p作为一个在iPSC-NSCs-Exos中丰富的关键miRNA,准LRIG3.
- 功能性救援实验证实了let-7b-5p/LRIG3通路在减轻SCI诱导的炎症中的作用.
结论:
- iPSC-NSCs-Exos提供let-7b-5p来调节LRIG3,减少微质/巨细胞灭,并改善SCI后的运动功能.
- 这项研究揭示了SCI的新治疗机制,涉及外体miRNAs.
- 结合iPSC-NSCs-Exos和let-7b-5p的联合治疗对SCI的功能恢复和炎症控制有希望.
相关概念视频
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...


